Treating Hepatitis C Virus Reinfection With 8 Weeks of Ledipasvir/Sofosbuvir Achieves Sustained Virologic Response.

Kelsey M Rife Erin J Lea Amy A Hirsch Yngve Falck-Ytter

Fed Pract

is a Hepatology Clinical Pharmacy Specialist, is an Infectious Diseases Clinical Pharmacist, is the Chief of the Gastroenterology and Hepatology Section, and is a Behavioral Health Psychologist, all at US Department of Veterans Affairs Northeast Ohio Healthcare System in Cleveland. Yngve Falck-Ytter is a Professor of Medicine, Erin Lea is an Adjunct Assistant Professor in the Department of Psychological Sciences, and Amy Hirsch is a Senior Clinical Instructor in the College of Medicine, all at Case Western Reserve University. Yngve Falck-Ytter is Faculty for the Gastroenterology Fellowship Program at University Hospitals.

Published: June 2021

Three patients reinfected with hepatitis C virus after a sustained virologic response were considered treatment naïve and treated with a short-course direct acting antiviral regimen.

Download full-text PDF	Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8560044	PMC
http://dx.doi.org/10.12788/fp.0137	DOI Listing

Publication Analysis

Top Keywords

hepatitis virus

sustained virologic

virologic response

treating hepatitis

virus reinfection

reinfection weeks

weeks ledipasvir/sofosbuvir

ledipasvir/sofosbuvir achieves

achieves sustained

response three

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!